Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Spinazzi

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|May 20, 1999
Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA)R Manfredi, G Maresca, R L Baron, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 14, 1998
Gadobenate dimeglumine (BOPTA) enhanced MR imaging: patterns of enhancement in normal liver and cirrhosisR Manfredi, G Maresca, R L Baron, et al.
American Journal of Medical Genetics. Part A|April 5, 2023
Adverse childhood experiences and the development of Down syndrome regression disorderSarah Wang, Lina Patel, Elise A Sannar, et al.
Journal of Neurodevelopmental Disorders|October 25, 2023
Hypovitaminosis D in persons with Down syndrome and autism spectrum disorderNatalie K Boyd, Julia Nguyen, Mellad M Khoshnood, et al.
AJR. American Journal of Roentgenology|September 23, 2000
Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesionsG Pirovano, A Vanzulli, L Marti-Bonmati, et al.
Korean Journal of Radiology|January 5, 2002
Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trialC S Peña, S Saini, R L Baron, et al.
The British Journal of Radiology|January 20, 2006
Diagnostic efficacy of SonoVue, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: a multicentre studyP S Sidhu, P L Allan, F Cattin, et al.
Molecular Autism|January 29, 2026
Serum and cerebral folate are normal in down syndrome regression disorderJonathan D Santoro, Mackenzie Silverman, Lilia Kazerooni, et al.
Scientific Reports|December 28, 2024
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Laura Keehan, et al.
Neurology and Therapy|March 8, 2026
A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression DisorderJonathan D Santoro, Saba Jafarpour, Panteha Hayati Rezvan, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Magnetic Resonance Imaging : JMRI|May 20, 1999
Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA)R Manfredi, G Maresca, R L Baron, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 14, 1998
Gadobenate dimeglumine (BOPTA) enhanced MR imaging: patterns of enhancement in normal liver and cirrhosisR Manfredi, G Maresca, R L Baron, et al.
American Journal of Medical Genetics. Part A|April 5, 2023
Adverse childhood experiences and the development of Down syndrome regression disorderSarah Wang, Lina Patel, Elise A Sannar, et al.
Journal of Neurodevelopmental Disorders|October 25, 2023
Hypovitaminosis D in persons with Down syndrome and autism spectrum disorderNatalie K Boyd, Julia Nguyen, Mellad M Khoshnood, et al.
AJR. American Journal of Roentgenology|September 23, 2000
Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesionsG Pirovano, A Vanzulli, L Marti-Bonmati, et al.
Korean Journal of Radiology|January 5, 2002
Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trialC S Peña, S Saini, R L Baron, et al.
The British Journal of Radiology|January 20, 2006
Diagnostic efficacy of SonoVue, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: a multicentre studyP S Sidhu, P L Allan, F Cattin, et al.
Molecular Autism|January 29, 2026
Serum and cerebral folate are normal in down syndrome regression disorderJonathan D Santoro, Mackenzie Silverman, Lilia Kazerooni, et al.
Scientific Reports|December 28, 2024
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Laura Keehan, et al.
Neurology and Therapy|March 8, 2026
A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression DisorderJonathan D Santoro, Saba Jafarpour, Panteha Hayati Rezvan, et al.
Pageof 5